The leading representative office of defined VC is situated in the Philadelphia. The company was established in North America in United States.
Besides them, we counted 5 critical employees of this fund in our database.
The important activity for fund was in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2019. The real fund results show that this VC is 7 percentage points less often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. Comparing to the other companies, this Quaker Partners performs on 16 percentage points less the average number of lead investments.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Quaker Partners, startups are often financed by Quaker BioVentures, New Enterprise Associates, H.I.G. BioHealth Partners. The meaningful sponsors for the fund in investment in the same round are New Enterprise Associates, H.I.G. BioHealth Partners, TVM Capital. In the next rounds fund is usually obtained by Quaker BioVentures, New Enterprise Associates, Three Arch Partners.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Medical Device, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Rapid Micro Biosystems, Vesper Medical, Intact Vascular.
Funds with similar focus
|Affinity Capital Management||Minneapolis, Minnesota, United States|
|Breakpoint Ventures||Chicago, Illinois, United States|
|Bridge Information Systems||-|
|Centre Capital Developpement||Centre-Loire Valley, France, Orléans|
|Ignition Group||Italy, Lombardia, Milano|
|Koonras Technologies||Israel, Tel Aviv, Tel Aviv District|
|Nassau Street Ventures||Boston, Massachusetts, United States|
|Odysseus Investments||Luxembourg, Luxembourg|
|Oracle Strategic Partners||Connecticut, Greenwich, United States|
|Park West Asset Management||California, Larkspur, United States|
|Privaris||Charlottesville, United States, Virginia|
|Rockport Venture Partners||New Jersey, Spring Lake, United States|
|Sabby Management||New Jersey, Saddle River, United States|
|Shenzhen Linhong Ruifeng Touzi Guanli Youxian Zeren Gongsi||China, Guangdong, Tianjin|
|Tactics II Investments||-|
|Wasserstein Adelson Ventures||New York, New York, United States|
|Yuliang Electronic Commerce||China, Yiwu, Zhejiang|
|Zhencheng Capital||Beijing, Beijing, China|
|$25M||30 May 2019||Radnor Township, Pennsylvania, United States|
|$37M||29 May 2019||Radnor Township, Pennsylvania, United States|
|$5M||24 Apr 2019||Auckland, Auckland, New Zealand|
|$10M||12 May 2018||Radnor Township, Pennsylvania, United States|
|$20M||16 Apr 2018||Radnor Township, Pennsylvania, United States|
|$25M||30 Oct 2017||Pennsylvania, United States|
|$7M||03 Jan 2017||Radnor Township, Pennsylvania, United States|
|$38M||14 May 2015||Radnor Township, Pennsylvania, United States|
Rapid Micro Biosystems
|$25M||29 Apr 2015||Massachusetts, United States|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.